Nova Biomedical Corp

Nova Biomedical Corp, a privately-held manufacturer of point-of-care diagnostic equipment and in-vitro testing devices headquartered in Waltham, Massachusetts, is a wholly-owned division of Advanced Instruments LLC and competes as a prime contractor (100% of recent awards) supplying blood gas analyzers, glucose monitoring systems, electrolyte testing instruments, and associated consumables to federal health agencies on full-and-open procurement with no set-aside usage.

The company's federal footprint spans 807 awards totaling $21.2 million in combined potential value across 49 distinct customer agencies, with 77% obligated. Activity has accelerated notably — from thirteen awards per year in 2022 to twenty-two in 2024 — though 2025 and early 2026 show a slower pace (fifteen and two awards respectively in those periods). Nine awards valued at $1.6 million total reach ultimate completion within the next twenty-four months and face recompete.

Nova's customer concentration sits with the Veterans Health Administration and Defense Health Agency. VHA Veterans Integrated Service Network 15 leads by potential value ($2.7 million across twenty awards), while the Defense Health Agency carries $1.9 million across twelve awards. The National Institute of Allergy and Infectious Diseases, with eight awards valued at $1.6 million, anchors the NIH relationship. VA VISN 21, VISN 16, and Navy Bureau of Medicine and Surgery round out the top tier. The vendor also maintains relationships with the Indian Health Service, Federal Correctional Complex Butner, National Institute of Standards and Technology, and the Food and Drug Administration. By award count, Indian Health Service leads (twenty-seven awards, $319 thousand combined value), but this ranking tracks smaller individual orders; dollar-driven customers concentrate with VA and Defense Health Agency.

Nova operates across the GSA Multiple Award Schedule (MAS) as its dominant vehicle, with 33 task orders valued at $2.2 million, and holds seats on numerous Federal Supply Schedules, including GS24F1306C (98 task orders, $1.5 million), GS00F2482A (22 task orders), and others. Work breaks down by NAICS predominantly under Analytical Laboratory Instrument Manufacturing (267 awards) and Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (31 awards); PSC coding reflects Medical and Surgical Instruments (245 awards), Laboratory Equipment and Supplies (183 awards), and Hospital Furniture and Equipment (91 awards).

Recent representative prime work includes a $843.7 thousand definitive contract from Defense Health Agency for StatStrip glucose testing supplies and monitors through December 2029 at Fort Sam Houston, Texas; a $512.2 thousand single-award indefinite delivery contract from Federal Correctional Complex Butner for whole blood glucose meters and test supplies through March 2027; a $254.3 thousand purchase order from VA San Francisco Healthcare System (VISN 21) for StatStrip glucose strips and meter warranty through March 2031; a $219.4 thousand Defense Health Agency purchase order for StatStrip glucose meters at Camp Pendleton through January 2028; and a $214.8 thousand purchase order from the National Institute of Allergy and Infectious Diseases for Nova Flex 2 analytical laboratory consumables supporting the Vaccine Production Program. Nova also supplies diagnostic equipment to the National Institute of Standards and Technology ($175.6 thousand for mammalian cell culture analysis system), the Indian Health Service through cost-per-test reagent rental agreements, and the FDA for nutrient analyzer parts and components. The vendor holds single-award blanket purchase agreements with VA VISN 16 for critical care electrolyte and ionized calcium analyzers ($139.9 thousand ceiling through September 2030) and Defense Health Agency for glucometer supplies at Fort Eisenhower ($189.2 thousand through September 2028).

Nova carries one documented sub-award, a $50 thousand service maintenance agreement under Weems Design Studio, Inc. for bioprofile analyzer support to the National Institute of Allergy and Infectious Diseases Vaccine Research Center. The company's competitive posture across 807 awards reflects consistent execution in medical device supply and diagnostic equipment provisioning to established federal healthcare customer relationships rather than pursuit of set-aside or emerging-market opportunities.